Back to Market Feed

DOVATO 50-300 MG TABLET

dolutegravir sodium and lamivudine
$105.2870per EA

Strength

50; 300 mg/1; mg/1

NDC

49702024613

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2026

Approval Type

New Drug (NDA)

FDA Application

NDA211994

On Market Since

4/8/2019

Pharmacological Classes

HIV Integrase Inhibitors
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Multidrug and Toxin Extrusion Transporter 1 Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Organic Cation Transporter 2 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.0%

1Y

+5.3%

3Y

+16.1%

5Y

+29.4%

All

+42.1%

Generic Alternatives

1 alternative • Same active ingredient

DOVATO 50-300 MG TABLET
Brand
49702024633•ViiV Healthcare Company
$105.2874

Related Drugs

Same classification

EPIVIR 10 MG/ML ORAL SOLN
Brand
49702020548•ViiV Healthcare Company
$0.4452
per ML
ZIAGEN 20 MG/ML SOLUTION
Brand
49702022248•ViiV Healthcare Company
$0.5865
per ML
EPIVIR 150 MG TABLET
Brand
49702020318•ViiV Healthcare Company
$6.6144
per EA
LAMICTAL 25 MG TABLET
Brand
00173063302•GlaxoSmithKline LLC
$10.2773
per EA
LAMICTAL 100 MG TABLET
Brand
00173064255•GlaxoSmithKline LLC
$10.9197
per EA
INTELENCE 100 MG TABLET
Brand
59676057001•Janssen Products LP
$10.9213
per EA
LAMICTAL 25 MG DISPER TABLET
Brand
00173052700•GlaxoSmithKline LLC
$11.2131
per EA
LAMICTAL 150 MG TABLET
Brand
00173064360•GlaxoSmithKline LLC
$11.4710
per EA
LAMICTAL 200 MG TABLET
Brand
00173064460•GlaxoSmithKline LLC
$12.0609
per EA
LAMICTAL ODT 25 MG TABLET
Brand
00173077202•GlaxoSmithKline LLC
$12.8016
per EA